Literature DB >> 24934115

Phosphoglycerate kinase deficiency due to a novel mutation (c. 1180A>G) manifesting as chronic hemolytic anemia in a Japanese boy.

Masato Tamai1, Takeshi Kawano, Ryota Saito, Ken Sakurai, Yoshihiro Saito, Hisashi Yamada, Hiroyuki Ida, Masaharu Akiyama.   

Abstract

Phosphoglycerate kinase (PGK) deficiency, a rare X-linked inherited disorder, manifests as various combinations of hemolytic anemia, neurological dysfunction, and myopathy. We report a Japanese boy with PGK deficiency presenting as chronic hemolytic anemia. The diagnosis of PGK1 deficiency was made at 11 months of age on the basis of low PGK enzyme activity (36.7 IU/g Hb; normal, 264-326 IU/g Hb) and the identification through PGK1 gene sequencing of a novel missense mutation: c. 1180A>G at exon 10. The mutation, which has been designated PGK-Aoto, results in a Thr394Ala amino-acid substitution at β-strand L. Because β-strand L plays an important role in the function of the hinge connecting the two domains of PGK, the Thr394Ala substitution may perturb this motion. At 3 years of age the patient has transfusion-dependent hemolytic anemia but no evidence of neuromuscular disease or developmental delay. Long-term follow-up will be needed to identify possible future clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24934115     DOI: 10.1007/s12185-014-1615-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  25 in total

1.  Phosphoglycerate kinase deficiency: an adult myopathic form with a novel mutation.

Authors:  T Hamano; T Mutoh; H Sugie; H Koga; M Kuriyama
Journal:  Neurology       Date:  2000-03-14       Impact factor: 9.910

2.  Two new phosphoglycerate kinase mutations associated with chronic haemolytic anaemia and neurological dysfunction in two patients from Spain.

Authors:  Núria Noel; Jonathan M Flanagan; John Flanagan; Maria Jose Ramirez Bajo; Susana G Kalko; María del Mar Mañú; José Luis Garcia Fuster; Pablo Perez de la Ossa; Josep Carreras; Ernest Beutler; Joan-Lluís Vives Corrons
Journal:  Br J Haematol       Date:  2006-02       Impact factor: 6.998

3.  Recurrent myoglobinuria in a child with mental retardation: phosphoglycerate kinase deficiency.

Authors:  H Sugie; Y Sugie; M Nishida; M Ito; S Tsurui; M Suzuki; R Miyamoto; Y Igarashi
Journal:  J Child Neurol       Date:  1989-04       Impact factor: 1.987

4.  Intronic mutation in the PGK1 gene may cause recurrent myoglobinuria by aberrant splicing.

Authors:  Kentaro Shirakawa; Yoshitomo Takahashi; Hiroaki Miyajima
Journal:  Neurology       Date:  2006-03-28       Impact factor: 9.910

5.  Use of cultured lymphoblastoid cells for the study of abnormal enzymes: molecular abnormality of a phosphoglycerate kinase variant associated with hemolytic anemia.

Authors:  H Fujii; S H Chen; J Akatsuka; S Miwa; A Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

6.  Enzymatic and metabolic characterization of the phosphoglycerate kinase deficiency associated with chronic hemolytic anemia caused by the PGK-Barcelona mutation.

Authors:  María José Ramírez-Bajo; Ada Repiso; Pablo Pérez de la Ossa; Elisenda Bañón-Maneus; Pedro de Atauri; Fernando Climent; Joan-Lluís Vives Corrons; Marta Cascante; José Carreras
Journal:  Blood Cells Mol Dis       Date:  2011-01-26       Impact factor: 3.039

7.  Altered expression of PGK1 in a family with phosphoglycerate kinase deficiency.

Authors:  Eva K Svaasand; Jan Aasly; Veslemøy Malm Landsem; Helge Klungland
Journal:  Muscle Nerve       Date:  2007-11       Impact factor: 3.217

8.  Molecular abnormality of phosphoglycerate kinase-Uppsala associated with chronic nonspherocytic hemolytic anemia.

Authors:  H Fujii; A Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

9.  Myopathic form of phosphoglycerate kinase (PGK) deficiency: a new case and pathogenic considerations.

Authors:  Ronen Spiegel; Estela Area Gomez; Hasan O Akman; Sindu Krishna; Yoseph Horovitz; Salvatore DiMauro
Journal:  Neuromuscul Disord       Date:  2009-01-20       Impact factor: 4.296

Review 10.  A novel missense mutation (1060G --> C) in the phosphoglycerate kinase gene in a Japanese boy with chronic haemolytic anaemia, developmental delay and rhabdomyolysis.

Authors:  Akira Morimoto; Ikuyo Ueda; Yoshiaki Hirashima; Yasuko Sawai; Tomohiro Usuku; Gen Kano; Kikuko Kuriyama; Shinjiro Todo; Tohru Sugimoto; Hitoshi Kanno; Hisaichi Fujii; Shinsaku Imashuku
Journal:  Br J Haematol       Date:  2003-09       Impact factor: 6.998

View more
  4 in total

1.  A novel PGK1 mutation associated with neurological dysfunction and the absence of episodes of hemolytic anemia or myoglobinuria.

Authors:  Shigeto Matsumaru; Hirokazu Oguni; Hiromi Ogura; Keiko Shimojima; Satoru Nagata; Hitoshi Kanno; Toshiyuki Yamamoto
Journal:  Intractable Rare Dis Res       Date:  2017-05

2.  Clinical Severity of PGK1 Deficiency Due To a Novel p.E120K Substitution Is Exacerbated by Co-inheritance of a Subclinical Translocation t(3;14)(q26.33;q12), Disrupting NUBPL Gene.

Authors:  Dezső David; Lígia S Almeida; Maristella Maggi; Carlos Araújo; Stefan Imreh; Giovanna Valentini; György Fekete; Irén Haltrich
Journal:  JIMD Rep       Date:  2015-03-27

Review 3.  Skeletal muscle disorders of glycogenolysis and glycolysis.

Authors:  Richard Godfrey; Ros Quinlivan
Journal:  Nat Rev Neurol       Date:  2016-05-27       Impact factor: 42.937

4.  A Novel Missense Variant Associated with A Splicing Defect in A Myopathic Form of PGK1 Deficiency in The Spanish Population.

Authors:  Virginia Garcia-Solaesa; Pablo Serrano-Lorenzo; Maria Antonia Ramos-Arroyo; Alberto Blázquez; Inmaculada Pagola-Lorz; Mercè Artigas-López; Joaquín Arenas; Miguel A Martín; Ivonne Jericó-Pascual
Journal:  Genes (Basel)       Date:  2019-10-10       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.